Reduced Lysyl Oxidase-Like (LOXL) in the Skin and Heart
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Lysyl Oxidase Family Members in Urological Tumorigenesis and Fibrosis
www.oncotarget.com Oncotarget, 2018, Vol. 9, (No. 28), pp: 20156-20164 Review Lysyl oxidase family members in urological tumorigenesis and fibrosis Tao Li1,2, Changjing Wu1, Liang Gao3, Feng Qin1, Qiang Wei2 and Jiuhong Yuan1,2 1The Andrology Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan, China 2Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China 3Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China Correspondence to: Jiuhong Yuan, email: [email protected] Keywords: lysyl oxidase; tumorigenesis; fibrosis; urological cancer; collagen Received: September 29, 2017 Accepted: March 11, 2018 Published: April 13, 2018 Copyright: Li et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Lysyl oxidase (LOX) is an extracellular copper-dependent monoamine oxidase that catalyzes crosslinking of soluble collagen and elastin into insoluble, mature fibers. Lysyl oxidase-like proteins (LOXL), LOX isozymes with partial structural homology, exhibit similar catalytic activities. This review summarizes recent findings describing the roles of LOX family members in urological cancers and fibrosis. LOX/ LOXL play key roles in extracellular matrix stability and integrity, which is essential for normal female pelvic floor function. LOX/LOXL inhibition may reverse kidney fibrosis and ischemic priapism. LOX and LOXL2 reportedly promote kidney carcinoma tumorigenesis, while LOX, LOXL1 and LOXL4 suppress bladder cancer growth. Multiple studies agree that the LOX propeptide may suppress tumor growth, but the role of LOX in prostate cancer remains controversial. -
The Function and Mechanisms of Action of LOXL2 in Cancer (Review)
1200 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 36: 1200-1204, 2015 The function and mechanisms of action of LOXL2 in cancer (Review) LINGHONG WU and YING ZHU Department of Infectious Diseases, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China Received May 31, 2015; Accepted August 26, 2015 DOI: 10.3892/ijmm.2015.2337 Abstract. The lysyl oxidase (LOX) family is comprised of five copper‑dependent amine oxidase, and its main role is to members, and some members have recently emerged as impor- catalyze the covalent cross‑link of collagen and elastin in tant regulators of tumor progression. Among these, at present, the extracellular matrix (ECM). This occurs through the LOX‑like (LOXL)2 is the prototypical LOX and the most oxidative deamination of peptidyl lysine residues in ECM comprehensively studied member. A growing body of evidence components (1,2). Each member of the LOX family has a has implicated LOXL2 in the promotion of cancer cell inva- highly conserved carboxyl (C)‑terminal domain that contains a sion, metastasis and angiogenesis, as well as in the malignant copper‑binding motif, lysine tyrosylquinone (LTQ) residues and transformation of solid tumors. Moreover, a high expression of a cytokine receptor‑like (CRL) domain, which is essential for LOXL2 is associated with a poor prognosis. These data have catalytic activity (3). The amino‑terminal regions are different piqued the interest of a number of researchers and research and are thought to be important in protein‑protein interactions. groups, who have identified LOXL2 as a strong target candidate The prodomains in LOX and LOXL1 enable their secretion in the development of inhibitors for use as functional and effi- as inactive proenzymes, which are then activated extracel- cacious tumor therapeutics. -
Genetic Analyses of Human Fetal Retinal Pigment Epithelium Gene Expression Suggest Ocular Disease Mechanisms
ARTICLE https://doi.org/10.1038/s42003-019-0430-6 OPEN Genetic analyses of human fetal retinal pigment epithelium gene expression suggest ocular disease mechanisms Boxiang Liu 1,6, Melissa A. Calton2,6, Nathan S. Abell2, Gillie Benchorin2, Michael J. Gloudemans 3, 1234567890():,; Ming Chen2, Jane Hu4, Xin Li 5, Brunilda Balliu5, Dean Bok4, Stephen B. Montgomery 2,5 & Douglas Vollrath2 The retinal pigment epithelium (RPE) serves vital roles in ocular development and retinal homeostasis but has limited representation in large-scale functional genomics datasets. Understanding how common human genetic variants affect RPE gene expression could elu- cidate the sources of phenotypic variability in selected monogenic ocular diseases and pin- point causal genes at genome-wide association study (GWAS) loci. We interrogated the genetics of gene expression of cultured human fetal RPE (fRPE) cells under two metabolic conditions and discovered hundreds of shared or condition-specific expression or splice quantitative trait loci (e/sQTLs). Co-localizations of fRPE e/sQTLs with age-related macular degeneration (AMD) and myopia GWAS data suggest new candidate genes, and mechan- isms by which a common RDH5 allele contributes to both increased AMD risk and decreased myopia risk. Our study highlights the unique transcriptomic characteristics of fRPE and provides a resource to connect e/sQTLs in a critical ocular cell type to monogenic and complex eye disorders. 1 Department of Biology, Stanford University, Stanford, CA 94305, USA. 2 Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA. 3 Program in Biomedical Informatics, Stanford University School of Medicine, Stanford 94305 CA, USA. 4 Department of Ophthalmology, Jules Stein Eye Institute, UCLA, Los Angeles 90095 CA, USA. -
LOXL1 Confers Antiapoptosis and Promotes Gliomagenesis Through Stabilizing BAG2
Cell Death & Differentiation (2020) 27:3021–3036 https://doi.org/10.1038/s41418-020-0558-4 ARTICLE LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2 1,2 3 4 3 4 3 1 1 Hua Yu ● Jun Ding ● Hongwen Zhu ● Yao Jing ● Hu Zhou ● Hengli Tian ● Ke Tang ● Gang Wang ● Xiongjun Wang1,2 Received: 10 January 2020 / Revised: 30 April 2020 / Accepted: 5 May 2020 / Published online: 18 May 2020 © The Author(s) 2020. This article is published with open access Abstract The lysyl oxidase (LOX) family is closely related to the progression of glioma. To ensure the clinical significance of LOX family in glioma, The Cancer Genome Atlas (TCGA) database was mined and the analysis indicated that higher LOXL1 expression was correlated with more malignant glioma progression. The functions of LOXL1 in promoting glioma cell survival and inhibiting apoptosis were studied by gain- and loss-of-function experiments in cells and animals. LOXL1 was found to exhibit antiapoptotic activity by interacting with multiple antiapoptosis modulators, especially BAG family molecular chaperone regulator 2 (BAG2). LOXL1-D515 interacted with BAG2-K186 through a hydrogen bond, and its lysyl 1234567890();,: 1234567890();,: oxidase activity prevented BAG2 degradation by competing with K186 ubiquitylation. Then, we discovered that LOXL1 expression was specifically upregulated through the VEGFR-Src-CEBPA axis. Clinically, the patients with higher LOXL1 levels in their blood had much more abundant BAG2 protein levels in glioma tissues. Conclusively, LOXL1 functions as an important mediator that increases the antiapoptotic capacity of tumor cells, and approaches targeting LOXL1 represent a potential strategy for treating glioma. -
LOXL3 Function Beyond Amino Oxidase and Role in Pathologies, Including Cancer
International Journal of Molecular Sciences Review LOXL3 Function Beyond Amino Oxidase and Role in Pathologies, Including Cancer Talita de S. Laurentino * , Roseli da S. Soares, Suely K. N. Marie and Sueli M. Oba-Shinjo Laboratory of Molecular and Cellular Biology (LIM 15), Department of Neurology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP 01246-903, Brazil * Correspondence: [email protected]; Tel.: +55-11-3061-8310 Received: 19 June 2019; Accepted: 15 July 2019; Published: 23 July 2019 Abstract: Lysyl oxidase like 3 (LOXL3) is a copper-dependent amine oxidase responsible for the crosslinking of collagen and elastin in the extracellular matrix. LOXL3 belongs to a family including other members: LOX, LOXL1, LOXL2, and LOXL4. Autosomal recessive mutations are rare and described in patients with Stickler syndrome, early-onset myopia and non-syndromic cleft palate. Along with an essential function in embryonic development, multiple biological functions have been attributed to LOXL3 in various pathologies related to amino oxidase activity. Additionally, various novel roles have been described for LOXL3, such as the oxidation of fibronectin in myotendinous junction formation, and of deacetylation and deacetylimination activities of STAT3 to control of inflammatory response. In tumors, three distinct roles were described: (1) LOXL3 interacts with SNAIL and contributes to proliferation and metastasis by inducing epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma cells; (2) LOXL3 is localized predominantly in the nucleus associated with invasion and poor gastric cancer prognosis; (3) LOXL3 interacts with proteins involved in DNA stability and mitosis completion, contributing to melanoma progression and sustained proliferation. Here we review the structure, function and activity of LOXL3 in normal and pathological conditions and discuss the potential of LOXL3 as a therapeutic target in various diseases. -
Identification of the Involvement of LOXL4 in Generation of Keratocystic Odontogenic Tumors by RNA-Seq Analysis
International Journal of Oral Science (2013) 6, 31–38 ß 2013 WCSS. All rights reserved 1674-2818/13 www.nature.com/ijos ORIGINAL ARTICLE Identification of the involvement of LOXL4 in generation of keratocystic odontogenic tumors by RNA-Seq analysis Wei-Peng Jiang1, Zi-Han Sima1, Hai-Cheng Wang1, Jian-Yun Zhang1, Li-Sha Sun2, Feng Chen2 and Tie-Jun Li1 Keratocystic odontogenic tumors (KCOT) are benign, locally aggressive intraosseous tumors of odontogenic origin. KCOT have a higher stromal microvessel density (MVD) than dentigerous cysts (DC) and normal oral mucosa. To identify genes in the stroma of KCOT involved in tumor development and progression, RNA sequencing (RNA-Seq) was performed using samples from KCOT and primary stromal fibroblasts isolated from gingival tissues. Seven candidate genes that possess a function potentially related to KCOT progression were selected and their expression levels were confirmed by quantitative PCR, immunohistochemistry and enzyme-linked immunosorbent assay. Expression of lysyl oxidase-like 4 (LOXL4), the only candidate gene that encodes a secreted protein, was enhanced at both the mRNA and protein levels in KCOT stromal tissues and primary KCOT stromal fibroblasts compared to control tissues and primary fibroblasts (P,0.05). In vitro, high expression of LOXL4 could enhance proliferation and migration of the human umbilical vein endothelial cells (HUVECs). There was a significant, positive correlation between LOXL4 protein expression and MVD in stroma of KCOT and control tissues (r50.882). These data suggest that abnormal expression of LOXL4 of KCOT may enhance angiogenesis in KCOT, which may help to promote the locally aggressive biological behavior of KCOT. -
Cell-Deposited Matrix Improves Retinal Pigment Epithelium Survival on Aged Submacular Human Bruch’S Membrane
Retinal Cell Biology Cell-Deposited Matrix Improves Retinal Pigment Epithelium Survival on Aged Submacular Human Bruch’s Membrane Ilene K. Sugino,1 Vamsi K. Gullapalli,1 Qian Sun,1 Jianqiu Wang,1 Celia F. Nunes,1 Noounanong Cheewatrakoolpong,1 Adam C. Johnson,1 Benjamin C. Degner,1 Jianyuan Hua,1 Tong Liu,2 Wei Chen,2 Hong Li,2 and Marco A. Zarbin1 PURPOSE. To determine whether resurfacing submacular human most, as cell survival is the worst on submacular Bruch’s Bruch’s membrane with a cell-deposited extracellular matrix membrane in these eyes. (Invest Ophthalmol Vis Sci. 2011;52: (ECM) improves retinal pigment epithelial (RPE) survival. 1345–1358) DOI:10.1167/iovs.10-6112 METHODS. Bovine corneal endothelial (BCE) cells were seeded onto the inner collagenous layer of submacular Bruch’s mem- brane explants of human donor eyes to allow ECM deposition. here is no fully effective therapy for the late complications of age-related macular degeneration (AMD), the leading Control explants from fellow eyes were cultured in medium T cause of blindness in the United States. The prevalence of only. The deposited ECM was exposed by removing BCE. Fetal AMD-associated choroidal new vessels (CNVs) and/or geo- RPE cells were then cultured on these explants for 1, 14, or 21 graphic atrophy (GA) in the U.S. population 40 years and older days. The explants were analyzed quantitatively by light micros- is estimated to be 1.47%, with 1.75 million citizens having copy and scanning electron microscopy. Surviving RPE cells from advanced AMD, approximately 100,000 of whom are African explants cultured for 21 days were harvested to compare bestro- American.1 The prevalence of AMD increases dramatically with phin and RPE65 mRNA expression. -
LOXL3 Antibody (C-Term) Affinity Purified Rabbit Polyclonal Antibody (Pab) Catalog # Ap12837b
10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 LOXL3 Antibody (C-term) Affinity Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP12837b Specification LOXL3 Antibody (C-term) - Product Information Application WB, IHC-P,E Primary Accession P58215 Other Accession Q9Z175, NP_115992.1 Reactivity Human Predicted Mouse Host Rabbit Clonality Polyclonal Isotype Rabbit Ig Antigen Region 715-744 LOXL3 Antibody (C-term) - Additional Information Gene ID 84695 Other Names Anti-LOXL3 Antibody (C-term) at 1:2000 Lysyl oxidase homolog 3, 143-, Lysyl dilution + human heart lysate oxidase-like protein 3, LOXL3, LOXL Lysates/proteins at 20 µg per lane. Secondary Goat Anti-Rabbit IgG, (H+L), Target/Specificity Peroxidase conjugated at 1/10000 dilution. This LOXL3 antibody is generated from Predicted band size : 83 kDa rabbits immunized with a KLH conjugated Blocking/Dilution buffer: 5% NFDM/TBST. synthetic peptide between 715-744 amino acids from the C-terminal region of human LOXL3. Dilution WB~~1:2000 IHC-P~~1:10~50 Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. Storage Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. All lanes : Anti-LOXL3 Antibody (C-term) at 1:2000 dilution Lane 1: human lung lysate Precautions Lane 2: human spleen lysate Lysates/proteins LOXL3 Antibody (C-term) is for research use at 20 µg per lane. -
Transdifferentiation of Human Mesenchymal Stem Cells
Transdifferentiation of Human Mesenchymal Stem Cells Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Julius-Maximilians-Universität Würzburg vorgelegt von Tatjana Schilling aus San Miguel de Tucuman, Argentinien Würzburg, 2007 Eingereicht am: Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Martin J. Müller Gutachter: PD Dr. Norbert Schütze Gutachter: Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am: Hiermit erkläre ich ehrenwörtlich, dass ich die vorliegende Dissertation selbstständig angefertigt und keine anderen als die von mir angegebenen Hilfsmittel und Quellen verwendet habe. Des Weiteren erkläre ich, dass diese Arbeit weder in gleicher noch in ähnlicher Form in einem Prüfungsverfahren vorgelegen hat und ich noch keinen Promotionsversuch unternommen habe. Gerbrunn, 4. Mai 2007 Tatjana Schilling Table of contents i Table of contents 1 Summary ........................................................................................................................ 1 1.1 Summary.................................................................................................................... 1 1.2 Zusammenfassung..................................................................................................... 2 2 Introduction.................................................................................................................... 4 2.1 Osteoporosis and the fatty degeneration of the bone marrow..................................... 4 2.2 Adipose and bone -
LOXL3 (Lysyl Oxidase-Like 3) Kornelia Molnarne Szauter, Katalin Csiszar John A
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Mini Review LOXL3 (lysyl oxidase-like 3) Kornelia Molnarne Szauter, Katalin Csiszar John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA (KMS, KC) Published in Atlas Database: October 2008 Online updated version : http://AtlasGeneticsOncology.org/Genes/LOXL3ID44000ch2p13.html DOI: 10.4267/2042/44556 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2009 Atlas of Genetics and Cytogenetics in Oncology and Haematology Alternative splicing was detected in ESTs that appear Identity to represent tissue-specific splice forms of the LOXL3 Other names: EC 1.4.3.-, LOXL mRNA. The alternatively spliced LOXL3 mRNA lacks HGNC (Hugo): LOXL3 exons 1, 2, 3, and 5 with an exon-intron structure distinct from the full-length LOXL3, and additionally, Location: 2p13.3 contains 80 bps in its 5' UTR and 561 bps in its 3'UTR. The protein deduced from this alternative mRNA DNA/RNA retains the structural C-terminal elements of a LOX Note family protein and the fourth SRCR domain at its N- LOXL3 is part of the lysyl oxidase (LOX) family, the terminus and is predicted to encode a polypeptide of members of which are secreted extracellular matrix 392 amino acids with a predicted molecular mass of 44 enzymes. LOXL3 contains a C-terminal region that is kDa. conserved in all five isoforms of this copper-dependent In Northern blot analyses of multiple human tissue amine oxidase family. The domains included within samples, LOXL3 mRNA was detected at 3.1 kb using this region are a copper-binding site, lysyl and tyrosine PCR-generated (Maki et al., 2001) and at 3.3 kb using residues that form the lysyltyrosine-quinone cofactor EST-derived probes (Jourdan-LeSaux et al., 2001). -
The Structure, Function and Evolution of the Extracellular Matrix: a Systems-Level Analysis
The Structure, Function and Evolution of the Extracellular Matrix: A Systems-Level Analysis by Graham L. Cromar A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Molecular Genetics University of Toronto © Copyright by Graham L. Cromar 2014 ii The Structure, Function and Evolution of the Extracellular Matrix: A Systems-Level Analysis Graham L. Cromar Doctor of Philosophy Department of Molecular Genetics University of Toronto 2014 Abstract The extracellular matrix (ECM) is a three-dimensional meshwork of proteins, proteoglycans and polysaccharides imparting structure and mechanical stability to tissues. ECM dysfunction has been implicated in a number of debilitating conditions including cancer, atherosclerosis, asthma, fibrosis and arthritis. Identifying the components that comprise the ECM and understanding how they are organised within the matrix is key to uncovering its role in health and disease. This study defines a rigorous protocol for the rapid categorization of proteins comprising a biological system. Beginning with over 2000 candidate extracellular proteins, 357 core ECM genes and 524 functionally related (non-ECM) genes are identified. A network of high quality protein-protein interactions constructed from these core genes reveals the ECM is organised into biologically relevant functional modules whose components exhibit a mosaic of expression and conservation patterns. This suggests module innovations were widespread and evolved in parallel to convey tissue specific functionality on otherwise broadly expressed modules. Phylogenetic profiles of ECM proteins highlight components restricted and/or expanded in metazoans, vertebrates and mammals, indicating taxon-specific tissue innovations. Modules enriched for medical subject headings illustrate the potential for systems based analyses to predict new functional and disease associations on the basis of network topology. -
A Molecular Role for Lysyl Oxidase in Breast Cancer Invasion1
[CANCER RESEARCH 62, 4478–4483, August 1, 2002] A Molecular Role for Lysyl Oxidase in Breast Cancer Invasion1 Dawn A. Kirschmann,2 Elisabeth A. Seftor, Sheri F. T. Fong, Daniel R. C. Nieva, Colleen M. Sullivan, Elijah M. Edwards, Pascal Sommer, Katalin Csiszar, and Mary J. C. Hendrix Department of Anatomy and Cell Biology, Holden Comprehensive Cancer Center at The University of Iowa, The Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa 52242-1109 [D. A. K., E. A. S., D. R. C. N., C. M. S., E. M. E., M. J. C. H.]; Institut de Biologie et Chimie des Prote´ines, Lyon Cedex 07, France [P. S.]; and Pacific Biomedical Research Center, University of Hawaii, Honolulu, Hawaii 96822 [S. F. T. F., K. C.] ABSTRACT LOX is a copper-dependent amine oxidase that initiates the cova- lent cross-linking of collagens and elastin in extracellular matrices We identified previously an up-regulation in lysyl oxidase (LOX) ex- (reviewed in Refs. 3, 4). It is secreted as a M 50,000 glycosylated pression, an extracellular matrix remodeling enzyme, in a highly invasive/ r proenzyme, which is proteolytically processed by procollagen C pro- metastatic human breast cancer cell line, MDA-MB-231, compared with MCF-7, a poorly invasive/nonmetastatic breast cancer cell line. In this teinase (bone morphogenic protein-1) into a mature, biologically study, we demonstrate that the mRNA expression of LOX and other LOX active Mr 32,000 form (3, 4). The formation of collagen/elastin family members [lysyl oxidase-like (LOXL), LOXL2, LOXL3, and cross-links by LOX leads to an increase in tensile strength and LOXL4] was observed only in breast cancer cells with a highly invasive/ structural integrity, and is essential for normal connective tissue metastatic phenotype but not in poorly invasive/nonmetastatic breast function, embryonic development, and wound healing (3, 5).